"Salmonella typhimurium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER.
Descriptor ID |
D012486
|
MeSH Number(s) |
B03.440.450.425.800.200.825 B03.660.250.150.710.160.760
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Salmonella typhimurium".
Below are MeSH descriptors whose meaning is more specific than "Salmonella typhimurium".
This graph shows the total number of publications written about "Salmonella typhimurium" by people in this website by year, and whether "Salmonella typhimurium" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 1 | 0 | 1 |
2025 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Salmonella typhimurium" by people in Profiles.
-
Dynamic Fluorescence Imaging of Orally-administered Tumor-targeting Salmonella typhimurium A1-R Expressing Green Fluorescent Protein Trafficking Through the Gastrointestinal System to Target Fibrosarcomas in Nude Mice. In Vivo. 2025; 39(2):640-647.
-
Engineered Methioninase-expressing Tumor-targeting Salmonella typhimurium A1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine. Cancer Genomics Proteomics. 2025; 22(2):247-257.
-
The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo. In Vivo. 2025; 39(1):102-109.
-
Accurate and Safe Tumor Targeting of Orally-administered Salmonella typhimurium A1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude Mice. In Vivo. 2024; 38(6):2601-2609.